[1] |
PONTICELLI C, GLASSOCK R J.Glomerular diseases: membranous nephropathy-a modern view[J]. Clin J Am Soc Nephrol,2014,9(3):609-616.
|
[2] |
CHEN Y,LI P,CUI C,et al.Biopsy-proven kidney diseases in the elderly: clinical characteristics,renal histopathological spectrum and prognostic factors[J]. J Int Med Res,2016,44(5):1092-1102.
|
[3] |
MINER J H.The glomerular basement membrane[J]. Exp Cell Res,2012,318(9):973-978.
|
[4] |
任惠珠,王珊珊,郑妙艳,等. 肾小球基底膜中胶原的合成、降解与糖尿病肾病[J]. 国际内分泌代谢杂志,2015,35(4):252-254.
|
[5] |
MAO M,ALAVI M V,LABELLE-DUMAIS C,et al.Type Ⅳ collagens and basement membrane diseases: cell biology and pathogenic mechanisms[J]. Curr Top Membr,2015,76:61-116.
|
[6] |
RAVIDA A,MUSANTE L,KREIVI M,et al.Glycosylation patterns of kidney proteins differ in rat diabetic nephropathy[J]. Kidney Int,2015,87(5):963-974.
|
[7] |
National Kidney Foundation.K/DOQI clinical practice guidelines for chronic kidney disease:evaluation, classification, and stratification[J]. Am J Kidney Dis,2002, 39(2 Suppl 1):S1-S266.
|
[8] |
Clinical and Laboratory Standards Institute. Evaluation of precision performance of quantitative measurement methods[S]. EP5-A2,CLSI,2004.
|
[9] |
Clinical and Laboratory Standards Institute. Method comparison bias estimation using patient samples[S]. EP9-A2,CLSI,2010.
|
[10] |
Clinical and Laboratory Standards Institute. Evaluation of the linearity of quantitative measurement procedures[S]. EP6-A,CLSI,2003.
|
[11] |
XU X,WANG G,CHEN N,et al.Long-term exposure to air pollution and increased risk of membranous nephropathy in China[J]. J Am Soc Nephrol,2016,27(12):3739-3746.
|
[12] |
CHEN X,CHEN Y,SHI K,et al.Comparison of prognostic,clinical,and renal histopathological characteristics of overlapping idiopathic membranous nephropathy and IgA nephropathy versus idiopathic membranous nephropathy[J]. Sci Rep,2017,7(1):11468.
|
[13] |
LI Y,WANG J,ZHU X,et al.Urinary protein markers predict the severity of renal histological lesions in children with mesangial proliferative glomerulonephritis[J]. BMC Nephrol,2012,13:29.
|
[14] |
王蕾,康懿,符玉瑛,等. 尿Ⅳ型胶原酶免疫测定法的建立及其在糖尿病肾病中的应用[J]. 检验医学,2004,19(3):181-184.
|
[15] |
MAK K M,MEI R.Basement membrane type Ⅳ collagen and laminin: an overview of their biology and value as fibrosis biomarkers of liver disease[J]. Anat Rec(Hoboken),2017,300(8):1371-1390.
|
[16] |
MAHENDRAN K B,BHASKAR M V,SANTHA K,et al.Plasma and urinary type Ⅳ collagen levels for early detection of nephropathy in type 2 diabetes mellitus patients[J]. Int J Health Sci(Qassim),2016,10(4):492-498.
|